IL-2信号维持狼疮中致病性年龄相关B细胞的稳态
该研究通过转录组与单细胞分析发现,狼疮致病性年龄相关B细胞(ABC)中IL-2信号升高,IL2RB在ABC中富集且启动子染色质可及性增加。IL-2以阶段依赖方式促进ABC存活与分化,在狼疮倾向小鼠中给予IL-2可增加ABC与Treg数量但未改善疾病表现。SLE患者B细胞和ABC中亦观察到IL-2信号激活。
要点
- 狼疮患者ABC中IL-2信号较健康对照更明显。
- IL-2以阶段依赖方式促进ABC存活与分化。
- 狼疮倾向小鼠给IL-2后ABC与Treg增多但疾病未改善。
核心结论
- 本研究将ABC鉴定为IL-2的新靶点,拓展了对IL-2在SLE中作用的认识,并为其疗效差异提供线索。
研究设计与样本
- 研究采用整合转录组分析鉴定狼疮致病性ABC相关信号通路,并检测IL-2对ABC的影响。
- 在TLR7驱动的狼疮倾向小鼠中给予IL-2以评估疗效。
- 通过生物信息学分析进一步评估SLE患者ABC对IL-2的反应性。
主要发现
- 转录组与单细胞分析显示ABC中IL-2信号升高,SLE患者较健康对照的IL-2特征更明显。
- IL2RB在ABC中显著富集,其启动子染色质可及性增加。
- IL-2以阶段依赖方式促进ABC存活与分化,预先给予受体小鼠IL-2可促进过继转移ABC的持续存在。
- 在狼疮倾向小鼠中,给予IL-2使ABC和Treg群体均增加,但未改善疾病表现,ABC的增加更依赖疾病状态。
- 在研究者队列中ABC的IL-2受体表达升高且与ABC频率相关,SLE患者B细胞和ABC中亦观察到IL-2信号激活。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Despite expanding regulatory T (Treg) cells, low-dose interleukin-2 (IL-2) therapy shows variable clinical efficacy in systemic lupus erythematosus (SLE). Here, we investigated whether previously unrecognised effects of IL-2 on age-associated B cells (ABCs) explain this therapeutic heterogeneity. METHODS: Integrated transcriptomic analysis was used to identify the prevalent signalling pathways associated with lupus pathogenic ABCs. The effects of IL-2 on ABCs were examined. TLR7-driven lupus-prone mice were administered to assess the efficacy of IL-2 therapy. IL-2 responsiveness of ABC was further evaluated in patients with SLE through bioinformatic analysis. RESULTS: Transcriptomic and single-cell analyses revealed elevated IL-2 signalling in ABCs, with a more pronounced IL-2 signature in patients with SLE than in healthy controls. IL2RB, a subunit of the IL-2 receptor, was significantly enriched in ABCs and showed increased chromatin accessibility at its promoter. IL-2 promoted ABC survival and differentiation in a stage-dependent manner. Prior IL-2 administration to recipient mice promoted the persistence of adoptively transferred ABCs. In lupus-prone mice, IL-2 administration increased both ABC and Treg populations without ameliorating disease manifestations with ABC's promotion being more dependent on the disease condition. Additionally, ABCs showed elevated expression of IL-2 receptor correlating with ABC frequency in our cohorts, and activation of IL-2 signalling was further observed in B cells and ABCs from patients with SLE. CONCLUSIONS: This study identified ABCs as a novel target of IL-2, expanding the understanding of IL-2's role in SLE beyond the traditional Treg-centric view and offering insights into the variable therapeutic efficacy of IL-2 in this context.
引用
- Han X, Jiang Y, Gu S, et al. IL-2 signalling sustains pathogenic age-associated B cell homeostasis in lupus. Ann Rheum Dis. 2025. PMID: 40940283. doi:10.1016/j.ard.2025.08.012
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。